Compare · EYE vs STAA
EYE vs STAA
Side-by-side comparison of National Vision Holdings Inc. (EYE) and STAAR Surgical Company (STAA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EYE and STAA operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- EYE is the larger of the two at $1.55B, about 1.1x STAA ($1.38B).
- Over the past year, EYE is down 21.2% and STAA is up 57.3% - STAA leads by 78.5 points.
- EYE has been more active in the news (10 items in the past 4 weeks vs 9 for STAA).
- STAA has more recent analyst coverage (25 ratings vs 20 for EYE).
- Company
- National Vision Holdings Inc.
- STAAR Surgical Company
- Price
- $19.72+2.18%
- $27.22-2.00%
- Market cap
- $1.55B
- $1.38B
- 1M return
- +7.98%
- -5.89%
- 1Y return
- -21.19%
- +57.34%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- News (4w)
- 10
- 9
- Recent ratings
- 20
- 25
National Vision Holdings Inc.
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 2, 2021, the company operated through 1,205 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.
STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Latest EYE
- President, America's Best Banner Mark converted options into 11,728 shares and covered exercise/tax liability with 4,964 shares, increasing direct ownership by 38% to 24,603 units (SEC Form 4)
- Director Zulla Caitlin was granted 16,258 shares, increasing direct ownership by 74% to 38,138 units (SEC Form 4)
- Director Ofarrell Susan C was granted 14,571 shares, increasing direct ownership by 65% to 36,904 units (SEC Form 4)
- Director Nicholson Michael J was granted 11,350 shares, increasing direct ownership by 106% to 22,069 units (SEC Form 4)
- Director Mcgrann James M. was granted 11,350 shares, increasing direct ownership by 106% to 22,069 units (SEC Form 4)
- Director Johnson Susan S was granted 11,350 shares, increasing direct ownership by 26% to 55,050 units (SEC Form 4)
- Director Kelman Naomi was granted 11,350 shares, increasing direct ownership by 28% to 52,391 units (SEC Form 4)
- Director Hepner Virginia A was granted 11,350 shares, increasing direct ownership by 26% to 55,377 units (SEC Form 4)
- Director Armario Jose was granted 16,258 shares, increasing direct ownership by 33% to 66,159 units (SEC Form 4)
- National Vision Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Latest STAA
- SEC Form S-8 filed by STAAR Surgical Company
- SEC Form 4 filed by Director Wang Christopher Min Fang
- SEC Form 4 filed by Director Lebuhn Richard T.
- SEC Form 4 filed by Director Bradsher Neal C
- Director Butcher Arthur C converted options into 5,341 shares, increasing direct ownership by 127% to 9,549 units (SEC Form 4)
- SEC Form 4 filed by Director Zhou Lilian Yansheng
- STAAR Surgical Company filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director Silverman Lou converted options into 10,683 shares, increasing direct ownership by 2,249% to 11,158 units (SEC Form 4)
- Director Jiang Wei converted options into 10,683 shares, increasing direct ownership by 16% to 77,127 units (SEC Form 4)
- Director Zhou Lilian Yansheng was granted 3,530 shares, increasing direct ownership by 77% to 8,101 units (SEC Form 4)